claim: rlf-7 clinical trial showed rapid recovery from respiratory failure and inhibition of coronavirus replication in human lung cells
evidence_1: neurorx and relief therapeutics have found that rlf-100 (aviptadil) led to rapid recovery from respiratory failure in critically ill patients with covid-19.", "rlf-100 (aviptadil) shows rapid recovery from respiratory failure in critically ill covid-19 patients.", "article by don ward hackett references: rlf-100 (aviptadil) clinical trial showed rapid recovery from respiratory failure and inhibition of coronavirus replication fda grants expanded access protocol to rlf-100 (aviptadil) for respiratory failure in covid-19 fact checked by robert carlson, md fact checked by danielle reiter, rn \\+ 1 relevant links: cdc vaccination schedules vaccine price list vaccines for children report vaccine side effects sponsored links: discounts appointments clinical trials lab tests "
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  )